Literature DB >> 26541996

Gangliosides in breast cancer: new perspectives.

S Groux-Degroote1, Y Guérardel, S Julien, P Delannoy.   

Abstract

Gangliosides are essential compounds of the plasma membrane involved in cell adhesion, proliferation, and recognition processes, as well as in the modulation of signal transduction pathways. These functions are mainly supported by the glycan moiety, and changes in the structure of gangliosides occur under pathological conditions including cancers. With progress in mass spectrometric analysis of gangliosides, the role of gangliosides in breast cancer progression was recently demonstrated. In this review, we summarize current knowledge on the biosynthesis of gangliosides and of the role of disialogangliosides in triple-negative breast cancer progression and metastasis. New perspectives in breast cancer therapy targeting gangliosides are also discussed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26541996     DOI: 10.1134/S0006297915070020

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  7 in total

Review 1.  Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions.

Authors:  Yuh-Jin Liang
Journal:  Glycoconj J       Date:  2022-03-10       Impact factor: 2.916

Review 2.  Role of Cytokine-Induced Glycosylation Changes in Regulating Cell Interactions and Cell Signaling in Inflammatory Diseases and Cancer.

Authors:  Justine H Dewald; Florent Colomb; Marie Bobowski-Gerard; Sophie Groux-Degroote; Philippe Delannoy
Journal:  Cells       Date:  2016-11-29       Impact factor: 6.600

3.  Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects.

Authors:  Laura F Hutchins; Issam Makhoul; Peter D Emanuel; Angela Pennisi; Eric R Siegel; Fariba Jousheghany; Xueyan Guo; Anastas D Pashov; Behjatolah Monzavi-Karbassi; Thomas Kieber-Emmons
Journal:  Oncotarget       Date:  2017-10-23

4.  Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.

Authors:  Yuh-Jin Liang; Chen-Yu Wang; I-An Wang; Yi-Wen Chen; Li-Tzu Li; Chuang-Yu Lin; Ming-Yi Ho; Tsung-Lung Chou; Ya-Hui Wang; Shih-Pin Chiou; Yu-Ju Lin; John Yu
Journal:  Oncotarget       Date:  2017-07-18

5.  Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer.

Authors:  Venkatrao Vantaku; Sri Ramya Donepudi; Chandrashekar R Ambati; Feng Jin; Vasanta Putluri; Khoa Nguyen; Kimal Rajapakshe; Cristian Coarfa; Venkata Lokesh Battula; Yair Lotan; Nagireddy Putluri
Journal:  Oncotarget       Date:  2017-09-16

6.  Simulating the enzymes of ganglioside biosynthesis with Glycologue.

Authors:  Andrew G McDonald; Gavin P Davey
Journal:  Beilstein J Org Chem       Date:  2021-03-23       Impact factor: 2.883

Review 7.  Ganglioside GD3 synthase (GD3S), a novel cancer drug target.

Authors:  Jinyi Liu; Xiangjin Zheng; Xiaocong Pang; Li Li; Jinhua Wang; Cui Yang; Guanhua Du
Journal:  Acta Pharm Sin B       Date:  2018-07-25       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.